317 related articles for article (PubMed ID: 34923677)
1. Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.
Gopalakrishnan D; Elsayed AS; Hussein AA; Jing Z; Li Q; Wagner AA; Aboumohamed A; Roupret M; Balbay D; Wijburg C; Stockle M; Dasgupta P; Khan MS; Wiklund P; Hosseini A; Peabody J; Shigemura K; Trump D; Guru KA; Chatta G
Int J Urol; 2022 Mar; 29(3):197-205. PubMed ID: 34923677
[TBL] [Abstract][Full Text] [Related]
2. Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
Hussein AA; Elsayed AS; Aldhaam NA; Jing Z; Osei J; Kaouk J; Redorta JP; Menon M; Peabody J; Dasgupta P; Khan MS; Mottrie A; Stöckle M; Hemal A; Richstone L; Hosseini A; Wiklund P; Schanne F; Kim E; Ho Rha K; Guru KA
J Urol; 2019 Nov; 202(5):927-935. PubMed ID: 31188729
[TBL] [Abstract][Full Text] [Related]
3. Rates and Patterns of Recurrences and Survival Outcomes after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
Elsayed AS; Gibson S; Jing Z; Wijburg C; Wagner AA; Mottrie A; Dasgupta P; Peabody J; Hussein AA; Guru KA
J Urol; 2021 Feb; 205(2):407-413. PubMed ID: 32945729
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC.
Aldhaam NA; Elsayed AS; Jing Z; Richstone L; Wagner AA; Rha KH; Yuh B; Palou J; Khan MS; Menon M; Roupret M; Balbay D; Hosseini A; Wiklund P; Gaboardi F; Maatman TJ; Mottrie A; Wijburg C; Stöckle M; Hemal A; Kim E; Kaouk J; Hussein AA; Guru KA
J Urol; 2020 Jan; 203(1):57-61. PubMed ID: 31600114
[TBL] [Abstract][Full Text] [Related]
5. Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.
Necchi A; Pond GR; Smaldone MC; Pal SK; Chan K; Wong YN; Viterbo R; Sonpavde G; Harshman LC; Crabb S; Alva A; Chowdhury S; De Giorgi U; Srinivas S; Agarwal N; Bamias A; Baniel J; Golshayan AR; Ladoire S; Sternberg CN; Cerbone L; Yu EY; Bellmunt J; Vaishampayan U; Niegisch G; Hussain S; Bowles DW; Morales-Barrera R; Milowsky MI; Theodore C; Berthold DR; Sridhar SS; Powles T; Rosenberg JE; Galsky MD;
Eur Urol Focus; 2018 Dec; 4(6):937-945. PubMed ID: 28753879
[TBL] [Abstract][Full Text] [Related]
6. Robot Assisted Radical Cystectomy vs Open Radical Cystectomy: Over 10 years of the Mayo Clinic Experience.
Faraj KS; Abdul-Muhsin HM; Rose KM; Navaratnam AK; Patton MW; Eversman S; Singh R; Eversman WG; Cheney SM; Tyson MD; Castle EP
Urol Oncol; 2019 Dec; 37(12):862-869. PubMed ID: 31526651
[TBL] [Abstract][Full Text] [Related]
7. Early Oncologic Failure after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
Hussein AA; Saar M; May PR; Wijburg CJ; Richstone L; Wagner A; Wilson T; Yuh B; Redorta JP; Dasgupta P; Khan MS; Menon M; Peabody JO; Hosseini A; Gaboardi F; Mottrie A; Rha KH; Hemal A; Stockle M; Kelly J; Maatman TJ; Canda AE; Wiklund P; Guru KA;
J Urol; 2017 Jun; 197(6):1427-1436. PubMed ID: 27993668
[TBL] [Abstract][Full Text] [Related]
8. Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: Results of a propensity score matched comparison with open cohort from a single-centre series.
Simone G; Tuderti G; Misuraca L; Anceschi U; Ferriero M; Minisola F; Guaglianone S; Gallucci M
Eur J Surg Oncol; 2018 Sep; 44(9):1432-1438. PubMed ID: 29699838
[TBL] [Abstract][Full Text] [Related]
9. Upstaging and Survival Outcomes for Non-Muscle Invasive Bladder Cancer After Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
Iqbal U; Elsayed AS; Jing Z; Stöckle M; Wijburg C; Wiklund P; Hosseini A; Dasgupta P; Khan MS; Hemal A; Kim E; Wagner AA; Gaboardi F; Rha KH; Maatman TJ; Balbay D; Li Q; Hussein AA; Guru KA
J Endourol; 2021 Oct; 35(10):1541-1547. PubMed ID: 34139890
[No Abstract] [Full Text] [Related]
10. The role of neoadjuvant chemotherapy for patients with variant histology muscle invasive bladder cancer undergoing robotic cystectomy: Data from the International Robotic Cystectomy Consortium.
Cooke I; Abou Heidar N; Mahmood AW; Ahmad A; Jing Z; Stöckle M; Wagner AA; Roupret M; Kim E; Vasdev N; Balbay D; Rha KH; Aboumohamed A; Dasgupta P; Maatman TJ; Richstone L; Wiklund P; Gaboardi F; Li Q; Hussein AA; Guru K
Urol Oncol; 2024 Apr; 42(4):117.e17-117.e25. PubMed ID: 38429124
[TBL] [Abstract][Full Text] [Related]
11. Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
Koie T; Ohyama C; Makiyama K; Shimazui T; Miyagawa T; Mizutani K; Tsuchiya T; Kato T; Nakane K
Int J Urol; 2019 Mar; 26(3):334-340. PubMed ID: 30690817
[TBL] [Abstract][Full Text] [Related]
12. Editorial Comment to Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.
Leow JJ; Yong DZ; Chia PL
Int J Urol; 2022 Mar; 29(3):205. PubMed ID: 35144319
[No Abstract] [Full Text] [Related]
13. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches.
Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
[TBL] [Abstract][Full Text] [Related]
15. Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study.
Mazza P; Moran GW; Li G; Robins DJ; Matulay JT; Herr HW; Decastro GJ; McKiernan JM; Anderson CB
J Urol; 2018 Nov; 200(5):1005-1013. PubMed ID: 29787740
[TBL] [Abstract][Full Text] [Related]
16. Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Raza SJ; Wilson T; Peabody JO; Wiklund P; Scherr DS; Al-Daghmin A; Dibaj S; Khan MS; Dasgupta P; Mottrie A; Menon M; Yuh B; Richstone L; Saar M; Stoeckle M; Hosseini A; Kaouk J; Mohler JL; Rha KH; Wilding G; Guru KA
Eur Urol; 2015 Oct; 68(4):721-8. PubMed ID: 25985883
[TBL] [Abstract][Full Text] [Related]
17. Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer.
Nguyen DP; Al Hussein Al Awamlh B; Wu X; O'Malley P; Inoyatov IM; Ayangbesan A; Faltas BM; Christos PJ; Scherr DS
Eur Urol; 2015 Sep; 68(3):399-405. PubMed ID: 25709026
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-year Analysis.
Hussein AA; Dibaj S; Hinata N; Field E; O'leary K; Kuvshinoff B; Mohler JL; Wilding G; Guru KA
Urology; 2016 Nov; 97():124-129. PubMed ID: 27491964
[TBL] [Abstract][Full Text] [Related]
19. Relapses Rates and Patterns for Pathological T0 After Robot-Assisted Radical Cystectomy: Results From the International Robotic Cystectomy Consortium.
Elsayed AS; Iqbal U; Jing Z; Houenstein HA; Wijburg C; Wiklund P; Kim E; Stöckle M; Kelly J; Dasgupta P; Wagner AA; Kaouk J; Badani KK; Redorta JP; Mottrie A; Peabody JO; Rouprêt M; Balbay D; Richstone L; Rha KH; Aboumohamed A; Li Q; Hussein AA; Guru KA
Urology; 2022 Aug; 166():177-181. PubMed ID: 35461914
[TBL] [Abstract][Full Text] [Related]
20. Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands.
Hinsenveld FJ; Boormans JL; van der Poel HG; van der Schoot DKE; Vis AN; Aben KKH; Arends TJ; Ausems PJ; Baselmans D; Berger C; Berrens A; Bickerstaffe H; Bos SD; Braam M; Buddingh KT; Claus S; Dekker K; van Doeveren T; Einerhand S; Fossion L; van Gennep EJ; van Ginkel N; Palacios G; Hermans T; Hobijn MM; van Huystee SH; Jaspers-Valentijn M; Klaver OS; Koldewijn EL; Korsten L; Lenting A; Lentjes KJ; Luiting HB; van der Meer S; Nieuwenhuijzen JA; Noordzij MA; Nooter RI; Notenboom C; Oomen R; van Roermund J; de Rooij J; Roshani H; Schrier BP; van der Slot MA; Somford DM; Stelwagen PJ; Stroux A; van der West A; Wijsman BP; Windt W; van Zanten P; van Beek SC;
Urol Oncol; 2022 Feb; 40(2):60.e1-60.e9. PubMed ID: 34303597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
